Clinical Trials in Los Angeles

Showing 7201-7220 of 16,901 trials

A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms

NCT00441896

The study consists of cohorts where participants are randomized, in a 2:1 ratio, to 1 of 2 sequences, A and B. In each cohort, Sequence A, comprised of participants, who will receive ascending doses of ganaxolone and ascending doses of placebo. Sequence B, comprised of participants, who will receive ascending doses of placebo and ascending doses of ganaxolone. The dosing level in each subsequent cohort will be based upon experience gained from previous cohorts.

Infantile Spasms

Marinus Pharmaceuticals57 participantsStarted Jan 2007

Los Angeles, California, United States • Los Angeles, California, United States • Washington D.C., District of Columbia, United States +12 more locations

COMPLETEDPhase 2< 1 mile

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications

NCT04373460

To assess the efficacy and safety of Human coronavirus immune plasma (HCIP) to reduce the risk of hospitalization or death, the duration of symptoms and duration of nasopharyngeal or oropharyngeal viral shedding.

SARS-CoV 2

Johns Hopkins University1,225 participantsStarted Jun 2020

Birmingham, Alabama, United States • Chinle, Arizona, United States • Phoenix, Arizona, United States +26 more locations

A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications

Find Trials by Condition in Los Angeles

A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder

Anxiety and Reward Interaction and Prediction of Outcomes in Anorexia Nervosa

An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis

Dimethyl Fumarate (DMF) Observational Study

Study of Diroximel Fumarate in the Real-World Setting

Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

Decreasing Intraoperative Skin Damage in Prone Position Surgeries

P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris

Thrombosomes® in Bleeding Thrombocytopenic Patients Study

To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue

EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer

A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)

Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors